Author:
Oya Mototsugu,Takayanagi Atsushi,Horiguchi Akio,Mizuno Ryuichi,Ohtsubo Masafumi,Marumo Ken,Shimizu Nobuyoshi,Murai Masaru
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,General Medicine
Reference33 articles.
1. Figlin,R.A. (1999) Renal cell carcinoma: management of advanced disease. J. Urol., 161, 381–386, 386–387.
2. Blay,J.Y., Negrier,S., Combaret,V. et al. (1992) Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res., 52, 3317–3322.
3. Tsukamoto,T., Kumamoto,Y., Miyao,N., Masumori,N., Takahashi,A. and Yanase,M. (1992) Interleukin-6 in renal cell carcinoma. J. Urol., 148, 1778–1781, 1781–1782.
4. Blay,J.Y., Rossi,J.F., Wijdenes,J., Menetrier-Caux,C., Schemann,S., Negrier,S., Philip,T. and Favrot,M. (1997) Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int. J. Cancer, 72, 424–430.
5. Miki,S., Iwano,M., Miki,Y., Yamamoto,M., Tang,B., Yokokawa,K., Sonoda,T., Hirano,T. and Kishimoto,T. (1989) Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett., 250, 607–610.
Cited by
110 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献